Diazyme DZ-Lite SARS-CoV-2 IgM CLIA Kit

Downloads |
Independent Performance Validation Study
Cat#:130219016M
The Diazyme DZ-Lite SARS-CoV-2 IgM CLIA kit is an Emergency Use Authorization (EUA) test authorized by the U.S. FDA for use by authorized laboratories. The test is for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma (potassium EDTA, disodium EDTA and lithium heparin) to aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. |
|||
Description
The DZ-Lite SARS-CoV-2 IgM CLIA kit runs on the fully automated DZ-Lite 3000 Plus Chemiluminescence Analyzer The assay features:
|
|||
Configuration
100 tests/kit and is used in conjunction with the fully automated DZ-Lite 3000 Plus Chemiluminescence Analyzer |
|||
Required Notice
|